Allwegene Gene

Allwegene is committed to promoting technological development and industrial transformation in the gene sequencing industry. Leveraging cutting-edge next-generation sequencing (NGS) technology and high-performance computing (HPC) equipment as the hardware foundation, the company has built a large-scale multi-omics research and industrialization technology platform combining biotechnology (BT) and information technology (IT). The company has been recognized as a "Zhongguancun High-tech Enterprise" and a "National High-tech Enterprise," and has received the "Beijing New Technology, New Product (Service) Certificate." It has also gained support from Beijing's science and technology service industry promotion program and has been honored as a "Beijing Patent Cultivation Unit" and a "Gazelle Enterprise" in the Zhongguancun National Innovation Demonstration Zone. Additionally, the company has obtained nearly 20 software copyrights and multiple invention patents. The company boasts a team of highly skilled professionals with years of experience in the gene industry, including a robust and rigorous production R&D team, a bioinformatics analysis team with extensive experience in large-scale genomics research projects, senior operations management personnel with industry expertise, and internationally oriented talents with overseas work and study backgrounds. The team has established an advanced laboratory "7S" management system, ensuring stable, efficient, reliable, and readable omics data. Meanwhile, the self-developed AIMS system applies modern information management concepts to monitor the entire process from experimental sample reception, experimental operations, and data analysis to report generation. Through this system, the company has achieved the highest level of industrialization service system in the gene industry, characterized by "all actions have standards, all actions are controllable, all actions are recorded, and all actions are traceable," thus earning the trust and recognition of customers. Currently, Allwegene is rapidly developing and has formed three major industrial systems: providing systematic solutions for multi-omics researchers in large-scale gene sequencing, bioinformatics analysis, and related result validation; offering precise medical gene screening and diagnostic services for clinical applications; and providing comprehensive personalized gene health risk detection for public health management, along with prevention or intervention plans for related diseases or sub-health conditions. In the future, the Allwegene team will remain proactive, upholding the mission of "serving the public with gene technology," and contributing all its strength to the rapid development of scientific research, the health and longevity of every individual, and the harmony and beauty of the world!